IBRX R&D Expenses
Immunitybio Inc · R&D Expenses
IBRX R&D Expenses
Latest reported$234.00Mperiod ending
IBRX R&D Expenses ($446.00K → $234.00M)
Annual R&D Expenses
High-resolution chart · PNG
IBRX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 207,875,000 | |
| 190,144,000 | |
| 232,366,000 | |
| 248,149,000 | |
| 195,958,000 | |
| 139,507,000 | |
| 48,885,000 | |
| 53,418,000 | |
| 39,778,000 | |
| 26,546,000 | |
| 11,434,000 | |
| 1,595,000 | |
| 446,000 |